Vedolizumab-Associated Drug-Induced Liver Injury: A Case Series

Sailish Honap^{1

2}, Eva Sticova³, Eleni Theocharidou⁴, Philip Berry⁴, Peter M Irving^{1

2}, Mark A Samaan¹, Sreelakshmi Kotha⁴

Affiliations

¹ IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
² School of Immunology and Microbial Sciences, King's College London, London, UK.
³ Institute of Liver Studies, King's College London, London, UK.
⁴ Department of Hepatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Case Reports

Sailish Honap et al. Inflamm Bowel Dis. 2021.

. 2021 Feb 16;27(3):e32-e34.

doi: 10.1093/ibd/izaa286.

Sailish Honap^{1

2}, Eva Sticova³, Eleni Theocharidou⁴, Philip Berry⁴, Peter M Irving^{1

2}, Mark A Samaan¹, Sreelakshmi Kotha⁴

¹ IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
² School of Immunology and Microbial Sciences, King's College London, London, UK.
³ Institute of Liver Studies, King's College London, London, UK.
⁴ Department of Hepatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

No abstract available

Keywords: cholestasis; drug-induced liver injury; hepatitis; vedolizumab.

Publication types